Back to Search
JAMES FINKE, M.D.
M.D.
Pediatrics Physician
NPI: 1215062336Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
MD040271E(PA)
Research & Publications (20)
Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.
PMID 18927310·Clin Cancer Res·2008
8-other
Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning--is there still an upper age limit? A focus on myeloid neoplasia.
PMID 17508002·Leukemia·2007
6-review
A structural model of polyglutamine determined from a host-guest method combining experiments and landscape theory.
PMID 15345567·Biophys J·2004
8-other
Tumor-induced dysfunction in T lymphocytes: increased sensitivity to apoptosis.
PMID 15148573·Urologe A·2004
8-other
Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin.
PMID 12560442·J Clin Oncol·2003
3-trial
The role of stem cell transplantation in the treatment of follicular lymphoma.
PMID 12959354·Semin Cancer Biol·2003
6-review
Interleukin-1 beta folding between pH 5 and 7: experimental evidence for three-state folding behavior and robust transition state positions late in folding.
PMID 12475255·Biochemistry·2002
8-other
Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.
PMID 11300495·Clin Cancer Res·2001
8-other
Commitment to folded and aggregated states occurs late in interleukin-1 beta folding.
PMID 11112552·Biochemistry·2000
7-preclinical
Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1beta.
PMID 10642182·Biochemistry·2000
8-other
Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin.
PMID 11091217·Br J Haematol·2000
8-other
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.
PMID 19633691·Bone Marrow Transplant·2010
8-other
Successful treatment of severe acute intestinal graft-versus-host resistant to systemic and topical steroids with alemtuzumab.
PMID 19589480·Biol Blood Marrow Transplant·2009
8-other
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?
PMID 19387465·Leukemia·2009
8-other
Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival.
PMID 19604243·Br J Haematol·2009
8-other
Synthesis and EPR studies of 2'-deoxyuridines with alkynyl, rodlike linkages.
PMID 19609983·Chemistry·2009
8-other
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
PMID 19620487·J Clin Oncol·2009
8-other
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
PMID 19597025·J Clin Oncol·2009
3-trial
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
PMID 19652066·J Clin Oncol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 A ST
PHILADELPHIA, PA 19134 - Phone
- (215) 399-2706
Quick Facts
- NPI
- 1215062336
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile